TWLO vs XERS · P/E 1087, rev $2.91B vs rev $175.2M
Twilio Inc (TWLO) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported TWLO revenue for 2026-06-30 was $2.91B. Net income was $1.16B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
TWLO currently screens at market cap $16.67B and trailing P/E 1086.7. XERS currently screens at market cap $760.7M.
Not investment advice. Open the TWLO and XERS stock pages for the full models.
Not investment advice.